PDEZX
Price
$16.03
Change
-$0.34 (-2.08%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

PDEZX vs RNWFX

Header iconPDEZX vs RNWFX Comparison
Open Charts PDEZX vs RNWFXBanner chart's image
PGIM Jennison Emerging Markets Eq Opps Z
Price$16.03
Change-$0.34 (-2.08%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PDEZX vs RNWFX Comparison Chart
Loading...
VS
PDEZX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDEZX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. PDEZX (564M). RNWFX pays higher dividends than PDEZX: RNWFX (1.51) vs PDEZX (0.00). PDEZX was incepted earlier than RNWFX: PDEZX (10 years) vs RNWFX (22 years). PDEZX is a more actively managed with annual turnover of: 103.00 vs. RNWFX (32.00). PDEZX has a lower initial minimum investment than RNWFX: PDEZX (0) vs RNWFX (250). PDEZX annual gain was more profitable for investors over the last year : 20.19 vs. RNWFX (11.53). PDEZX return over 5 years is better than : 37.10 vs. RNWFX (22.38).
PDEZXRNWFXPDEZX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years22 years-
Gain YTD10.8337.245150%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets564M60.1B1%
Annual Yield % from dividends0.001.51-
Returns for 1 year20.1911.53175%
Returns for 3 years-35.50-15.44230%
Returns for 5 years37.1022.38166%
Returns for 10 yearsN/A35.71-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio